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PLASMA ADIPONECTIN IS A MARKER OF SEVERITY
IN HEART FAILURE
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Purpose. Adiponectin, a 247 aminoacid protein produced
mainly by adipose tissue, beside its effects on glucose me-
tabolism, plays important protective function against car-
diovascular disease. Adiponectin is inversely correlated
with an increased cardiovascular risk and hypo-adiponec-
tinemia is considered an independent cardiovascular risk
factor. On the contrary, the role of adiponectin in heart fai-
lure (HF) is not fully known. In order to evaluate the pro-
gnostic value of circulating adiponectin, we measured to-
tal adiponectin plasma levels in patients with HF of diffe-
rent severity.
Methods. Total adiponectin, leptin and interleukin(IL)-6 le-
vels were measured in plasma samples of 159 no diabetic
patients with different etiology HF (17 in NYHA class I, 82
in NYHA class II, 46 in NYHA class III and 14 in NYHA
class IV, age 62±14 yrs, LEVF% 32.5±0.79, mean±sem)
and in 31 healthy subjects as control, by dedicated ELI-
SA (Linco Res-US, DRG Diagnostics-Germany, Diaclone
Research-France, respectively). In the same group brain
natriuretic peptide (BNP) levels were determined by IRMA
(Shionogi, Osaka, Japan).
Results. Our findings indicated that total adiponectin le-
vels increased significantly as a function of disease se-
verity (7.1±0.61 mg/ml vs 10.9±1.4 in NYHA class I vs
12.8±0.95 in NYHA class II vs 15.7±1.3 in NYHA III vs
16.7±1.8 in NYHA class IV; p<0.001 NYHA II, III and IV
vs controls) and they correlated negatively with LVEF%
(p=0.0009), positively with cardiac function (BNP levels)
(p<0.0001) and inflammation (IL-6 levels) (p<0.0001). We
did not observe any correlation with metabolism (BMI) in
patients with HF, while a significant correlation was found
between leptin and BMI (p<0.0001).
Conclusion. Circulating adiponectin is associated with car-
diovascular function and inflammation in HF patients. The
increased adiponectin plasma levels in HF is a marker of
disease severity, indipendent of metabolism.
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PROSTATE SPECIFIC ANTIGEN (PSA) TO
EVALUATE SEMEN CONTAMINATION OF VAGINAL
FLUID
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Objective. Contaminants, such as semen, may affect
measurement of vaginal cytokines. We sought to compare
detection of semen contamination evaluated by prostate
specific antigen (PSA) to other frequently used assays.
Methods. This study is part of a larger nested case con-
trol study about microbial and immune parameters asso-
ciated with preterm birth among women with bacterial va-
ginosis (BV). At their first prenatal visit, participants we-
re interviewed and their vaginal secretions were obtained.
Swabs were Gram stained or inoculated into sterile saline
and snap frozen. Among a subset of patients, semen con-
tamination was assessed with: 1) measurement of total
PSA, 2) acid phosphatase activity, 3) microscopic measu-
rement of spermatozoa on Gram stain, and 4) self-repor-
ted sexual intercourse in the past two days. Sensitivity and
specificity were calculated for each technique in compari-
son to PSA levels.
Results. Of the 802 study participants with BV, a subset
of 302 samples were selected. Relevant demographic da-
ta were as follows: mean age of 24.1 years, 73.1% non-
Hispanic black, 85.5% U.S. born, 76.4% single, 41.8%
nulliparous, and 32.0% with less than high school edu-
cation. The mean gestational age at collection was 11.8
weeks. A total of 119 (39.4%) study participants had any
PSA detectable; 75 (28.6%) had PSA levels >1.0 ng/mL
and 25 (9.5%) had levels >150 ng/mL. Spermatozoa were
identified on Gram stain for 45 (15.2%) women, and 35
(11.6%) had elevated acid phosphatase levels. Sixty-nine
(23.3%) women reported having had sexual intercourse in
the previous 48 hours. Compared to measurable PSA le-
vels, the sensitivity and specificity for each technique were
as follows: acid phosphatase (26.9%, 98.4%), Gram stain
(36.1%, 98.4%), and self-report (41.9%, 88.8%).
Conclusion. Compared to PSA levels, commonly used as-
says for recent semen exposure are inaccurate. This inac-
curacy may affect the results of studies which measure va-
ginal immune factors like cytokines or retrieve DNA from
vaginal specimens.
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